Literature DB >> 25991511

Mesenchymal stromal cells and the acute respiratory distress syndrome (ARDS): challenges for clinical application.

J E Millar1, J F Fraser2, D F McAuley3.   

Abstract

Entities:  

Keywords:  ARDS; Bacterial Infection; Respiratory Infection

Mesh：

Year:  2015        PMID： 25991511     DOI： 10.1136/thoraxjnl-2015-207121

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  2 in total

Review 1.  The influence of macrophages on mesenchymal stromal cell therapy: passive or aggressive agents?

Authors:  F Carty; B P Mahon; K English
Journal:  Clin Exp Immunol       Date:  2017-02-20       Impact factor: 4.330

2.  Combined Mesenchymal Stromal Cell Therapy and Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome. A Randomized Controlled Trial in Sheep.

Authors:  Jonathan E Millar; Nicole Bartnikowski; Margaret R Passmore; Nchafatso G Obonyo; Maximillian V Malfertheiner; Viktor von Bahr; Meredith A Redd; Louise See Hoe; Katrina K Ki; Sanne Pedersen; Andrew J Boyle; J Kenneth Baillie; Kiran Shekar; Nathan Palpant; Jacky Y Suen; Michael A Matthay; Daniel F McAuley; John F Fraser
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.